

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of vitamin D biosynthetic process (GO:0060556) | 6.23400045 |
| 2 | NIK/NF-kappaB signaling (GO:0038061) | 5.83971497 |
| 3 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 5.35605538 |
| 4 | response to muramyl dipeptide (GO:0032495) | 5.07062080 |
| 5 | regulation of vitamin metabolic process (GO:0030656) | 5.00935598 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.96210953 |
| 7 | tolerance induction (GO:0002507) | 4.95893167 |
| 8 | positive thymic T cell selection (GO:0045059) | 4.85958893 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.82323020 |
| 10 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.81345270 |
| 11 | interferon-gamma production (GO:0032609) | 4.67667785 |
| 12 | regulation of gamma-delta T cell activation (GO:0046643) | 4.59190870 |
| 13 | negative T cell selection (GO:0043383) | 4.58537357 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.56353205 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.56353205 |
| 16 | negative thymic T cell selection (GO:0045060) | 4.55488030 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.49019907 |
| 18 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.44868142 |
| 19 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.38771302 |
| 20 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.23281472 |
| 21 | thymic T cell selection (GO:0045061) | 4.23167650 |
| 22 | positive T cell selection (GO:0043368) | 4.14085064 |
| 23 | regulation of interferon-alpha production (GO:0032647) | 4.02785746 |
| 24 | negative regulation of cell killing (GO:0031342) | 3.99347946 |
| 25 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.99347946 |
| 26 | myeloid dendritic cell differentiation (GO:0043011) | 3.95848133 |
| 27 | T cell selection (GO:0045058) | 3.90269562 |
| 28 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.88002438 |
| 29 | T-helper 1 type immune response (GO:0042088) | 3.87515694 |
| 30 | activation of MAPKKK activity (GO:0000185) | 3.86727015 |
| 31 | response to interleukin-15 (GO:0070672) | 3.86414869 |
| 32 | regulation of podosome assembly (GO:0071801) | 3.85947590 |
| 33 | response to peptidoglycan (GO:0032494) | 3.85219230 |
| 34 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.85162028 |
| 35 | negative regulation of interleukin-12 production (GO:0032695) | 3.84814246 |
| 36 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.82312619 |
| 37 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.76939035 |
| 38 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.73768871 |
| 39 | T-helper cell differentiation (GO:0042093) | 3.73768871 |
| 40 | myeloid dendritic cell activation (GO:0001773) | 3.72092219 |
| 41 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.71160405 |
| 42 | response to protozoan (GO:0001562) | 3.67563118 |
| 43 | cellular response to interleukin-15 (GO:0071350) | 3.64182663 |
| 44 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.62932061 |
| 45 | T cell migration (GO:0072678) | 3.59241454 |
| 46 | growth hormone receptor signaling pathway (GO:0060396) | 3.57951872 |
| 47 | positive regulation of interferon-alpha production (GO:0032727) | 3.55455377 |
| 48 | defense response to protozoan (GO:0042832) | 3.54369634 |
| 49 | leukocyte aggregation (GO:0070486) | 3.53169623 |
| 50 | germinal center formation (GO:0002467) | 3.49553949 |
| 51 | immunoglobulin mediated immune response (GO:0016064) | 3.45201642 |
| 52 | regulation of chemokine biosynthetic process (GO:0045073) | 3.44895870 |
| 53 | positive regulation of interleukin-2 production (GO:0032743) | 3.44686071 |
| 54 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.40138497 |
| 55 | positive regulation of type 2 immune response (GO:0002830) | 3.37428001 |
| 56 | T cell differentiation involved in immune response (GO:0002292) | 3.36031025 |
| 57 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.36031025 |
| 58 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.36031025 |
| 59 | regulation of T cell tolerance induction (GO:0002664) | 3.34312316 |
| 60 | regulation of chronic inflammatory response (GO:0002676) | 3.30853178 |
| 61 | positive regulation of heat generation (GO:0031652) | 3.26921177 |
| 62 | regulation of immunoglobulin secretion (GO:0051023) | 3.26132875 |
| 63 | regulation of T-helper cell differentiation (GO:0045622) | 3.22259909 |
| 64 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.22205561 |
| 65 | positive regulation of isotype switching (GO:0045830) | 3.19508872 |
| 66 | macrophage activation involved in immune response (GO:0002281) | 3.18069935 |
| 67 | positive regulation of interleukin-12 production (GO:0032735) | 3.12948497 |
| 68 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.12603043 |
| 69 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.11898981 |
| 70 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.11342876 |
| 71 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.10833758 |
| 72 | regulation of response to interferon-gamma (GO:0060330) | 3.10601877 |
| 73 | natural killer cell activation (GO:0030101) | 3.09622395 |
| 74 | T cell activation involved in immune response (GO:0002286) | 3.07212889 |
| 75 | negative regulation of viral genome replication (GO:0045071) | 3.06366073 |
| 76 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.06188369 |
| 77 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.06054987 |
| 78 | T cell receptor signaling pathway (GO:0050852) | 3.05916172 |
| 79 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.05552703 |
| 80 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.05552703 |
| 81 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.05552703 |
| 82 | modulation by symbiont of host immune response (GO:0052553) | 3.05552703 |
| 83 | positive regulation by symbiont of host defense response (GO:0052509) | 3.05552703 |
| 84 | modulation by symbiont of host defense response (GO:0052031) | 3.05552703 |
| 85 | negative regulation of bone resorption (GO:0045779) | 3.05344207 |
| 86 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.03510430 |
| 87 | hepatocyte apoptotic process (GO:0097284) | 3.02462252 |
| 88 | cellular response to interferon-gamma (GO:0071346) | 3.01797857 |
| 89 | cellular response to growth hormone stimulus (GO:0071378) | 3.01726871 |
| 90 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.01626462 |
| 91 | alpha-beta T cell activation (GO:0046631) | 3.00490837 |
| 92 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.00034662 |
| 93 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.99965664 |
| 94 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.99460022 |
| 95 | alpha-beta T cell differentiation (GO:0046632) | 2.99005483 |
| 96 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.98816934 |
| 97 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.97394716 |
| 98 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.96925954 |
| 99 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.95376448 |
| 100 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.95295502 |
| 101 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.94838660 |
| 102 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.92637079 |
| 103 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.92161744 |
| 104 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.92161744 |
| 105 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.91653090 |
| 106 | dendritic cell differentiation (GO:0097028) | 2.91611277 |
| 107 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.90456300 |
| 108 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.90122792 |
| 109 | endothelial cell chemotaxis (GO:0035767) | 2.89272758 |
| 110 | mature B cell differentiation (GO:0002335) | 2.88700722 |
| 111 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.86354439 |
| 112 | cellular response to arsenic-containing substance (GO:0071243) | 2.85800357 |
| 113 | positive regulation of interferon-beta production (GO:0032728) | 2.85760871 |
| 114 | positive regulation of humoral immune response (GO:0002922) | 2.85527013 |
| 115 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.84871042 |
| 116 | cellular response to lipopolysaccharide (GO:0071222) | 2.84582484 |
| 117 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.84013135 |
| 118 | T cell costimulation (GO:0031295) | 2.83127206 |
| 119 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.82241547 |
| 120 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.82027939 |
| 121 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.79232939 |
| 122 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 2.78157158 |
| 123 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.77982383 |
| 124 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.77982383 |
| 125 | positive regulation of DNA recombination (GO:0045911) | 2.77962936 |
| 126 | regulation of interleukin-12 production (GO:0032655) | 2.77917000 |
| 127 | embryonic process involved in female pregnancy (GO:0060136) | 2.77504270 |
| 128 | lymphocyte costimulation (GO:0031294) | 2.76886131 |
| 129 | regulation of interleukin-2 production (GO:0032663) | 2.76563253 |
| 130 | positive regulation of interleukin-10 production (GO:0032733) | 2.76077359 |
| 131 | response to interferon-gamma (GO:0034341) | 2.75955837 |
| 132 | natural killer cell differentiation (GO:0001779) | 2.75311451 |
| 133 | protein localization to endosome (GO:0036010) | 2.74483776 |
| 134 | regulation of type 2 immune response (GO:0002828) | 2.74329550 |
| 135 | cellular response to molecule of bacterial origin (GO:0071219) | 2.73858549 |
| 136 | regulation of B cell differentiation (GO:0045577) | 2.73051568 |
| 137 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.72939276 |
| 138 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.72894463 |
| 139 | B cell mediated immunity (GO:0019724) | 2.72602413 |
| 140 | leukocyte cell-cell adhesion (GO:0007159) | 2.72560644 |
| 141 | response to type I interferon (GO:0034340) | 2.72045406 |
| 142 | cellular response to virus (GO:0098586) | 2.71351711 |
| 143 | neutrophil activation (GO:0042119) | 2.71235884 |
| 144 | cellular response to type I interferon (GO:0071357) | 2.71106194 |
| 145 | type I interferon signaling pathway (GO:0060337) | 2.71106194 |
| 146 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.68463266 |
| 147 | Peyers patch development (GO:0048541) | 2.68463266 |
| 148 | modulation by symbiont of host cellular process (GO:0044068) | 2.68086646 |
| 149 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.66858402 |
| 150 | positive regulation of interleukin-6 production (GO:0032755) | 2.66825993 |
| 151 | monocyte chemotaxis (GO:0002548) | 2.66007510 |
| 152 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.65748827 |
| 153 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.65715184 |
| 154 | lymphocyte migration (GO:0072676) | 2.65650777 |
| 155 | regulation of mononuclear cell migration (GO:0071675) | 2.65468629 |
| 156 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.65247518 |
| 157 | positive regulation of B cell mediated immunity (GO:0002714) | 2.65247518 |
| 158 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.65107125 |
| 159 | positive regulation of defense response to virus by host (GO:0002230) | 2.65089788 |
| 160 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.65021863 |
| 161 | positive regulation of p38MAPK cascade (GO:1900745) | 2.64884421 |
| 162 | mature B cell differentiation involved in immune response (GO:0002313) | 2.64624383 |
| 163 | granulocyte activation (GO:0036230) | 2.63870339 |
| 164 | regulation of antigen processing and presentation (GO:0002577) | 2.63109036 |
| 165 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.62732240 |
| 166 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.61244472 |
| 167 | regulation of RIG-I signaling pathway (GO:0039535) | 2.60388536 |
| 168 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.60340626 |
| 169 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.59692706 |
| 170 | positive regulation of antigen processing and presentation (GO:0002579) | 2.58821835 |
| 171 | regulation of fever generation (GO:0031620) | 2.58483319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.49346852 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.56489007 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.77691101 |
| 4 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.15898447 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.05855148 |
| 6 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.78581605 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.50710740 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.05706098 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.02360411 |
| 10 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.97129387 |
| 11 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.88875398 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.88248461 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.87494949 |
| 14 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.87140562 |
| 15 | * MYB_26560356_Chip-Seq_TH2_Human | 2.69025528 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.58569117 |
| 17 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.56166002 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.53082355 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.51266580 |
| 20 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.44533782 |
| 21 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.37899534 |
| 22 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.33440990 |
| 23 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31312623 |
| 24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.30973722 |
| 25 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.26292042 |
| 26 | * MYB_26560356_Chip-Seq_TH1_Human | 2.19729435 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.07761636 |
| 28 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.02660549 |
| 29 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.94425907 |
| 30 | UTX_26944678_Chip-Seq_JUKART_Human | 1.94304730 |
| 31 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.92156001 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.91991121 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.91784936 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.90119470 |
| 35 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.84431092 |
| 36 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.79842358 |
| 37 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.77474482 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.75902255 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.74940015 |
| 40 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.67912869 |
| 41 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.64724754 |
| 42 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.60096465 |
| 43 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.54157197 |
| 44 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.53563717 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.51353040 |
| 46 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.48921016 |
| 47 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.43714934 |
| 48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40937896 |
| 49 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.40203380 |
| 50 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.39669847 |
| 51 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.39577908 |
| 52 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.35989587 |
| 53 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.35989587 |
| 54 | * MAF_26560356_Chip-Seq_TH2_Human | 1.35896681 |
| 55 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29919210 |
| 56 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.28990479 |
| 57 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.28936129 |
| 58 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.26653836 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22777006 |
| 60 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22349676 |
| 61 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21634174 |
| 62 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.20520073 |
| 63 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.20520073 |
| 64 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.20520073 |
| 65 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.19160182 |
| 66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18967929 |
| 67 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.18596866 |
| 68 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.17620307 |
| 69 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.16762813 |
| 70 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.15981443 |
| 71 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15959167 |
| 72 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.14018540 |
| 73 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13723848 |
| 74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.13500037 |
| 75 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.11504971 |
| 76 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.11453562 |
| 77 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.11274903 |
| 78 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.10961761 |
| 79 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.08889778 |
| 80 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.04426501 |
| 81 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.03046054 |
| 82 | ATF3_27146783_Chip-Seq_COLON_Human | 1.02400867 |
| 83 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02387236 |
| 84 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.01933707 |
| 85 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01146461 |
| 86 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00883564 |
| 87 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.99819638 |
| 88 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99290925 |
| 89 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.98377291 |
| 90 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.98271054 |
| 91 | GATA3_26560356_Chip-Seq_TH2_Human | 0.97997155 |
| 92 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96654182 |
| 93 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96623587 |
| 94 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.96055596 |
| 95 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.95642410 |
| 96 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93963340 |
| 97 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93638645 |
| 98 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93623218 |
| 99 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92957270 |
| 100 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.92592993 |
| 101 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92224750 |
| 102 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92202986 |
| 103 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90422254 |
| 104 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.89864401 |
| 105 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.89531743 |
| 106 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88887269 |
| 107 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88349460 |
| 108 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.87109192 |
| 109 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.86857724 |
| 110 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.86766492 |
| 111 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.84441937 |
| 112 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80832028 |
| 113 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79696643 |
| 114 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.78526702 |
| 115 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78235755 |
| 116 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.76943122 |
| 117 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75060371 |
| 118 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73726145 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000685_abnormal_immune_system | 3.56633888 |
| 2 | MP0004510_myositis | 3.30919589 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.28790346 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.22170601 |
| 5 | MP0005671_abnormal_response_to | 3.13068548 |
| 6 | MP0005387_immune_system_phenotype | 3.09022968 |
| 7 | MP0001790_abnormal_immune_system | 3.09022968 |
| 8 | MP0003436_decreased_susceptibility_to | 3.08221750 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.92942439 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 2.85582013 |
| 11 | MP0002877_abnormal_melanocyte_morpholog | 2.78116353 |
| 12 | MP0001800_abnormal_humoral_immune | 2.75761361 |
| 13 | MP0005451_abnormal_body_composition | 2.73259502 |
| 14 | MP0003303_peritoneal_inflammation | 2.67733580 |
| 15 | MP0009785_altered_susceptibility_to | 2.60457264 |
| 16 | MP0004947_skin_inflammation | 2.60298018 |
| 17 | MP0009840_abnormal_foam_cell | 2.52211775 |
| 18 | MP0002723_abnormal_immune_serum | 2.49662116 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.47870419 |
| 20 | MP0002405_respiratory_system_inflammati | 2.46025357 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.43878181 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.35363102 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.32164256 |
| 24 | MP0001819_abnormal_immune_cell | 2.31851374 |
| 25 | MP0002166_altered_tumor_susceptibility | 2.31201432 |
| 26 | MP0010352_gastrointestinal_tract_polyps | 2.26481546 |
| 27 | MP0001853_heart_inflammation | 2.13333912 |
| 28 | MP0005025_abnormal_response_to | 2.09362153 |
| 29 | MP0010155_abnormal_intestine_physiology | 2.08541549 |
| 30 | MP0002006_tumorigenesis | 2.08303301 |
| 31 | MP0005058_abnormal_lysosome_morphology | 2.06972010 |
| 32 | MP0003724_increased_susceptibility_to | 2.01988809 |
| 33 | MP0002398_abnormal_bone_marrow | 2.01644128 |
| 34 | MP0002419_abnormal_innate_immunity | 1.94858232 |
| 35 | MP0001873_stomach_inflammation | 1.88889374 |
| 36 | MP0002139_abnormal_hepatobiliary_system | 1.88706513 |
| 37 | MP0000716_abnormal_immune_system | 1.87136478 |
| 38 | MP0005076_abnormal_cell_differentiation | 1.86154434 |
| 39 | MP0006082_CNS_inflammation | 1.80435200 |
| 40 | MP0002933_joint_inflammation | 1.77473369 |
| 41 | MP0003866_abnormal_defecation | 1.76448739 |
| 42 | MP0000703_abnormal_thymus_morphology | 1.74587896 |
| 43 | MP0001348_abnormal_lacrimal_gland | 1.74177968 |
| 44 | MP0002254_reproductive_system_inflammat | 1.69074142 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.65623424 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.62117085 |
| 47 | MP0003075_altered_response_to | 1.61730323 |
| 48 | MP0000858_altered_metastatic_potential | 1.61266118 |
| 49 | MP0002722_abnormal_immune_system | 1.60883503 |
| 50 | MP0001845_abnormal_inflammatory_respons | 1.60347162 |
| 51 | MP0003448_altered_tumor_morphology | 1.55291353 |
| 52 | MP0009278_abnormal_bone_marrow | 1.54755175 |
| 53 | MP0005310_abnormal_salivary_gland | 1.53808071 |
| 54 | MP0008004_abnormal_stomach_pH | 1.52086463 |
| 55 | MP0004808_abnormal_hematopoietic_stem | 1.48271058 |
| 56 | MP0000689_abnormal_spleen_morphology | 1.47721602 |
| 57 | MP0002429_abnormal_blood_cell | 1.45629611 |
| 58 | MP0002332_abnormal_exercise_endurance | 1.45457985 |
| 59 | MP0003453_abnormal_keratinocyte_physiol | 1.45028288 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.43151337 |
| 61 | MP0005397_hematopoietic_system_phenotyp | 1.34589955 |
| 62 | MP0001545_abnormal_hematopoietic_system | 1.34589955 |
| 63 | MP0001851_eye_inflammation | 1.31610979 |
| 64 | MP0002009_preneoplasia | 1.25891408 |
| 65 | MP0005464_abnormal_platelet_physiology | 1.24488093 |
| 66 | MP0005166_decreased_susceptibility_to | 1.21840736 |
| 67 | MP0006054_spinal_hemorrhage | 1.12127344 |
| 68 | MP0002277_abnormal_respiratory_mucosa | 1.11155822 |
| 69 | MP0008007_abnormal_cellular_replicative | 1.11088745 |
| 70 | MP0003091_abnormal_cell_migration | 1.10687650 |
| 71 | MP0000465_gastrointestinal_hemorrhage | 1.08178372 |
| 72 | MP0003566_abnormal_cell_adhesion | 1.07424645 |
| 73 | MP0008961_abnormal_basal_metabolism | 1.05765205 |
| 74 | MP0003950_abnormal_plasma_membrane | 1.05459673 |
| 75 | MP0000604_amyloidosis | 1.04944992 |
| 76 | MP0003045_fibrosis | 1.04886123 |
| 77 | MP0002396_abnormal_hematopoietic_system | 1.03066890 |
| 78 | MP0001216_abnormal_epidermal_layer | 1.02800200 |
| 79 | MP0002163_abnormal_gland_morphology | 1.00610625 |
| 80 | MP0010234_abnormal_vibrissa_follicle | 1.00170269 |
| 81 | MP0003172_abnormal_lysosome_physiology | 0.99950242 |
| 82 | MP0005165_increased_susceptibility_to | 0.99330354 |
| 83 | MP0001243_abnormal_dermal_layer | 0.98352977 |
| 84 | MP0005164_abnormal_response_to | 0.96439892 |
| 85 | MP0003191_abnormal_cellular_cholesterol | 0.96274870 |
| 86 | MP0005390_skeleton_phenotype | 0.96232540 |
| 87 | MP0000490_abnormal_crypts_of | 0.94379486 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 0.92548894 |
| 89 | MP0001881_abnormal_mammary_gland | 0.91812880 |
| 90 | MP0008469_abnormal_protein_level | 0.90333211 |
| 91 | MP0003795_abnormal_bone_structure | 0.89330671 |
| 92 | MP0003828_pulmonary_edema | 0.87882417 |
| 93 | MP0010307_abnormal_tumor_latency | 0.84529328 |
| 94 | MP0003806_abnormal_nucleotide_metabolis | 0.83886687 |
| 95 | MP0002693_abnormal_pancreas_physiology | 0.82778068 |
| 96 | MP0003183_abnormal_peptide_metabolism | 0.82033351 |
| 97 | MP0008057_abnormal_DNA_replication | 0.80345051 |
| 98 | MP0002060_abnormal_skin_morphology | 0.79741330 |
| 99 | MP0008260_abnormal_autophagy | 0.79542530 |
| 100 | MP0005023_abnormal_wound_healing | 0.77993276 |
| 101 | MP0001191_abnormal_skin_condition | 0.77906870 |
| 102 | MP0005167_abnormal_blood-brain_barrier | 0.76874109 |
| 103 | MP0002019_abnormal_tumor_incidence | 0.76173526 |
| 104 | MP0009764_decreased_sensitivity_to | 0.75740110 |
| 105 | MP0009765_abnormal_xenobiotic_induced | 0.74945458 |
| 106 | MP0002796_impaired_skin_barrier | 0.72170805 |
| 107 | MP0001727_abnormal_embryo_implantation | 0.71336090 |
| 108 | MP0000249_abnormal_blood_vessel | 0.69569525 |
| 109 | MP0000627_abnormal_mammary_gland | 0.68490729 |
| 110 | MP0003705_abnormal_hypodermis_morpholog | 0.66045912 |
| 111 | MP0008874_decreased_physiological_sensi | 0.65300869 |
| 112 | MP0003221_abnormal_cardiomyocyte_apopto | 0.64402639 |
| 113 | MP0005174_abnormal_tail_pigmentation | 0.59889119 |
| 114 | MP0000343_altered_response_to | 0.57855034 |
| 115 | MP0009763_increased_sensitivity_to | 0.56723117 |
| 116 | MP0000367_abnormal_coat/_hair | 0.56681276 |
| 117 | MP0004264_abnormal_extraembryonic_tissu | 0.56628034 |
| 118 | MP0002132_abnormal_respiratory_system | 0.55992953 |
| 119 | MP0002136_abnormal_kidney_physiology | 0.55436268 |
| 120 | MP0000613_abnormal_salivary_gland | 0.55167138 |
| 121 | MP0001502_abnormal_circadian_rhythm | 0.52575190 |
| 122 | MP0001542_abnormal_bone_strength | 0.52318254 |
| 123 | MP0001663_abnormal_digestive_system | 0.51484901 |
| 124 | MP0005621_abnormal_cell_physiology | 0.51243507 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Retrobulbar optic neuritis (HP:0100654) | 5.20794638 |
| 2 | Optic neuritis (HP:0100653) | 5.20794638 |
| 3 | Stomatitis (HP:0010280) | 5.15992755 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 5.01606810 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.01606810 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.01606810 |
| 7 | Myositis (HP:0100614) | 4.99233060 |
| 8 | Orchitis (HP:0100796) | 4.94916693 |
| 9 | Eczematoid dermatitis (HP:0000976) | 4.73620418 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.62096489 |
| 11 | Increased density of long bones (HP:0006392) | 3.98411386 |
| 12 | Recurrent fungal infections (HP:0002841) | 3.92726647 |
| 13 | Abnormality of T cell number (HP:0011839) | 3.75954239 |
| 14 | T lymphocytopenia (HP:0005403) | 3.69487795 |
| 15 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.66355529 |
| 16 | Persistence of primary teeth (HP:0006335) | 3.61609332 |
| 17 | Pulmonary infiltrates (HP:0002113) | 3.55491586 |
| 18 | Vacuolated lymphocytes (HP:0001922) | 3.52977637 |
| 19 | Arterial thrombosis (HP:0004420) | 3.49634060 |
| 20 | Nuclear cataract (HP:0100018) | 3.49592514 |
| 21 | Loss of speech (HP:0002371) | 3.49214946 |
| 22 | Mediastinal lymphadenopathy (HP:0100721) | 3.41522403 |
| 23 | Increased IgE level (HP:0003212) | 3.40196647 |
| 24 | Nasal polyposis (HP:0100582) | 3.37474250 |
| 25 | Vasculitis (HP:0002633) | 3.37148977 |
| 26 | Keratoconjunctivitis sicca (HP:0001097) | 3.36194887 |
| 27 | IgM deficiency (HP:0002850) | 3.33387866 |
| 28 | Recurrent bronchitis (HP:0002837) | 3.31103982 |
| 29 | Abnormality of T cells (HP:0002843) | 3.29976986 |
| 30 | Severe combined immunodeficiency (HP:0004430) | 3.29000817 |
| 31 | Gastrointestinal infarctions (HP:0005244) | 3.20828776 |
| 32 | Recurrent viral infections (HP:0004429) | 3.19806180 |
| 33 | Dysostosis multiplex (HP:0000943) | 3.18735028 |
| 34 | Chronic otitis media (HP:0000389) | 3.07076531 |
| 35 | Keratoconjunctivitis (HP:0001096) | 3.02553286 |
| 36 | Thyroiditis (HP:0100646) | 3.02467922 |
| 37 | Abnormality of T cell physiology (HP:0011840) | 2.99619568 |
| 38 | Panhypogammaglobulinemia (HP:0003139) | 2.92789789 |
| 39 | Increased IgM level (HP:0003496) | 2.88578949 |
| 40 | Recurrent abscess formation (HP:0002722) | 2.84516029 |
| 41 | Abnormality of the nasal mucosa (HP:0000433) | 2.83400872 |
| 42 | Recurrent cutaneous fungal infections (HP:0011370) | 2.80507316 |
| 43 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.80507316 |
| 44 | Disinhibition (HP:0000734) | 2.78376361 |
| 45 | Abnormality of B cell number (HP:0010975) | 2.73962780 |
| 46 | B lymphocytopenia (HP:0010976) | 2.73962780 |
| 47 | Increased cerebral lipofuscin (HP:0011813) | 2.72793900 |
| 48 | Leukocytosis (HP:0001974) | 2.72728825 |
| 49 | Hemoptysis (HP:0002105) | 2.72360461 |
| 50 | Combined immunodeficiency (HP:0005387) | 2.71132045 |
| 51 | Meningitis (HP:0001287) | 2.69934854 |
| 52 | Systemic lupus erythematosus (HP:0002725) | 2.69125223 |
| 53 | IgG deficiency (HP:0004315) | 2.69076777 |
| 54 | Interstitial pulmonary disease (HP:0006530) | 2.67167430 |
| 55 | Inflammation of the large intestine (HP:0002037) | 2.65821175 |
| 56 | Autoimmune hemolytic anemia (HP:0001890) | 2.58475717 |
| 57 | Recurrent bacterial skin infections (HP:0005406) | 2.58059583 |
| 58 | Abnormality of eosinophils (HP:0001879) | 2.58040325 |
| 59 | Abnormality of the fingertips (HP:0001211) | 2.57970420 |
| 60 | IgA deficiency (HP:0002720) | 2.53282688 |
| 61 | Neurofibrillary tangles (HP:0002185) | 2.50541312 |
| 62 | Gastrointestinal inflammation (HP:0004386) | 2.48716757 |
| 63 | Colitis (HP:0002583) | 2.48243768 |
| 64 | Joint swelling (HP:0001386) | 2.45206377 |
| 65 | Parakeratosis (HP:0001036) | 2.42284060 |
| 66 | Axonal loss (HP:0003447) | 2.39349045 |
| 67 | Myocardial infarction (HP:0001658) | 2.37745268 |
| 68 | Thrombocytosis (HP:0001894) | 2.37135051 |
| 69 | Hypergammaglobulinemia (HP:0010702) | 2.36391226 |
| 70 | Eosinophilia (HP:0001880) | 2.34653639 |
| 71 | Cellulitis (HP:0100658) | 2.34387785 |
| 72 | Malnutrition (HP:0004395) | 2.33531970 |
| 73 | Fatigue (HP:0012378) | 2.32718272 |
| 74 | Gingivitis (HP:0000230) | 2.29639017 |
| 75 | Encephalitis (HP:0002383) | 2.29462484 |
| 76 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.28390887 |
| 77 | Lymphopenia (HP:0001888) | 2.28378358 |
| 78 | Chest pain (HP:0100749) | 2.28032171 |
| 79 | Apathy (HP:0000741) | 2.26382121 |
| 80 | Restrictive lung disease (HP:0002091) | 2.24711961 |
| 81 | Tetraparesis (HP:0002273) | 2.24216176 |
| 82 | Increased serum ferritin (HP:0003281) | 2.21156083 |
| 83 | Hypertensive crisis (HP:0100735) | 2.20513023 |
| 84 | Abnormality of the nasal septum (HP:0000419) | 2.19373226 |
| 85 | Abnormality of macrophages (HP:0004311) | 2.17829002 |
| 86 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.17627138 |
| 87 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.17627138 |
| 88 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.17627138 |
| 89 | Pustule (HP:0200039) | 2.17447700 |
| 90 | Chronic diarrhea (HP:0002028) | 2.16037696 |
| 91 | Agammaglobulinemia (HP:0004432) | 2.15769454 |
| 92 | Gangrene (HP:0100758) | 2.12109687 |
| 93 | Recurrent skin infections (HP:0001581) | 2.11550883 |
| 94 | Urticaria (HP:0001025) | 2.11548561 |
| 95 | Diminished motivation (HP:0000745) | 2.11143756 |
| 96 | Emphysema (HP:0002097) | 2.09644308 |
| 97 | Mucopolysacchariduria (HP:0008155) | 2.09025901 |
| 98 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.09025901 |
| 99 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.08663017 |
| 100 | Anhidrosis (HP:0000970) | 2.08479728 |
| 101 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.07168269 |
| 102 | Glomerulopathy (HP:0100820) | 2.05460253 |
| 103 | Anorexia (HP:0002039) | 2.04647153 |
| 104 | Autoimmune thrombocytopenia (HP:0001973) | 2.03653767 |
| 105 | Thoracolumbar scoliosis (HP:0002944) | 2.02327036 |
| 106 | Hyperparathyroidism (HP:0000843) | 2.02138679 |
| 107 | Gastrointestinal stroma tumor (HP:0100723) | 2.01550159 |
| 108 | Premature loss of primary teeth (HP:0006323) | 2.01058924 |
| 109 | Abnormality of the pericardium (HP:0001697) | 2.00519998 |
| 110 | Polyneuropathy (HP:0001271) | 1.99453290 |
| 111 | Mutism (HP:0002300) | 1.98635569 |
| 112 | Arthralgia (HP:0002829) | 1.97883003 |
| 113 | Periodontitis (HP:0000704) | 1.97634818 |
| 114 | Upper motor neuron abnormality (HP:0002127) | 1.97549751 |
| 115 | Basal ganglia calcification (HP:0002135) | 1.97233112 |
| 116 | Granulocytopenia (HP:0001913) | 1.97175255 |
| 117 | Osteomyelitis (HP:0002754) | 1.95073377 |
| 118 | Spontaneous hematomas (HP:0007420) | 1.94769214 |
| 119 | Xerostomia (HP:0000217) | 1.93118702 |
| 120 | Acute myeloid leukemia (HP:0004808) | 1.92750871 |
| 121 | Amaurosis fugax (HP:0100576) | 1.92249876 |
| 122 | Cerebral inclusion bodies (HP:0100314) | 1.91725778 |
| 123 | Neuronal loss in central nervous system (HP:0002529) | 1.91071574 |
| 124 | Thin bony cortex (HP:0002753) | 1.90251090 |
| 125 | Bone pain (HP:0002653) | 1.88604018 |
| 126 | Pulmonary embolism (HP:0002204) | 1.88448012 |
| 127 | Bronchitis (HP:0012387) | 1.87560452 |
| 128 | Obstructive lung disease (HP:0006536) | 1.86875075 |
| 129 | Chronic obstructive pulmonary disease (HP:0006510) | 1.86875075 |
| 130 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.85832296 |
| 131 | Chronic sinusitis (HP:0011109) | 1.85740532 |
| 132 | Lymphoma (HP:0002665) | 1.85568611 |
| 133 | Hematochezia (HP:0002573) | 1.85465762 |
| 134 | Progressive neurologic deterioration (HP:0002344) | 1.85072788 |
| 135 | Abnormality of the pleura (HP:0002103) | 1.84871155 |
| 136 | Peritonitis (HP:0002586) | 1.83438723 |
| 137 | Glomerulonephritis (HP:0000099) | 1.82871754 |
| 138 | Thick nail (HP:0001805) | 1.82260003 |
| 139 | Keratitis (HP:0000491) | 1.80532073 |
| 140 | Spondylolisthesis (HP:0003302) | 1.80345777 |
| 141 | Cheilitis (HP:0100825) | 1.80173314 |
| 142 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.78033344 |
| 143 | Vertebral compression fractures (HP:0002953) | 1.78026832 |
| 144 | Stomach cancer (HP:0012126) | 1.75603551 |
| 145 | Gingival bleeding (HP:0000225) | 1.70726499 |
| 146 | Skin ulcer (HP:0200042) | 1.69840750 |
| 147 | Lip pit (HP:0100267) | 1.66075917 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.52923226 |
| 2 | TXK | 3.76553361 |
| 3 | PRPF4B | 3.76146165 |
| 4 | MAP4K1 | 3.74235853 |
| 5 | TBK1 | 2.84218320 |
| 6 | IKBKB | 2.76440301 |
| 7 | JAK3 | 2.70241231 |
| 8 | IRAK3 | 2.69217749 |
| 9 | MAP3K10 | 2.57805785 |
| 10 | IKBKE | 2.57504524 |
| 11 | CHUK | 2.47562627 |
| 12 | EPHB1 | 2.27804464 |
| 13 | ITK | 2.13000561 |
| 14 | EPHA3 | 2.12272647 |
| 15 | TYK2 | 2.00895575 |
| 16 | DDR2 | 1.94976930 |
| 17 | JAK1 | 1.94218280 |
| 18 | ZAP70 | 1.92159358 |
| 19 | GRK7 | 1.87445253 |
| 20 | MOS | 1.87382311 |
| 21 | FGFR4 | 1.77208879 |
| 22 | TAOK3 | 1.74906784 |
| 23 | NLK | 1.74828562 |
| 24 | MST4 | 1.72676945 |
| 25 | MAP3K3 | 1.68705983 |
| 26 | MATK | 1.68376926 |
| 27 | MAP2K3 | 1.63227430 |
| 28 | RPS6KA4 | 1.53529602 |
| 29 | STK10 | 1.51651530 |
| 30 | PIM2 | 1.47668882 |
| 31 | TSSK6 | 1.44811869 |
| 32 | IRAK4 | 1.44477451 |
| 33 | PIM1 | 1.43627076 |
| 34 | RIPK1 | 1.43109325 |
| 35 | FGFR3 | 1.41747057 |
| 36 | MAP3K13 | 1.33497349 |
| 37 | BTK | 1.31202726 |
| 38 | MAP3K11 | 1.30489876 |
| 39 | TEC | 1.30105467 |
| 40 | ARAF | 1.23669217 |
| 41 | LATS2 | 1.22292355 |
| 42 | MAP3K9 | 1.18496224 |
| 43 | HIPK2 | 1.17374452 |
| 44 | PTK6 | 1.15851414 |
| 45 | CDC42BPA | 1.15338311 |
| 46 | HCK | 1.14789719 |
| 47 | EEF2K | 1.14579878 |
| 48 | MAPK15 | 1.14354299 |
| 49 | LCK | 1.14238069 |
| 50 | CSK | 1.13627220 |
| 51 | GRK6 | 1.13063530 |
| 52 | TRIB3 | 1.13056424 |
| 53 | IRAK1 | 1.11169532 |
| 54 | FGR | 1.07603765 |
| 55 | SIK3 | 1.07542000 |
| 56 | EIF2AK3 | 1.06082375 |
| 57 | MST1R | 1.02568867 |
| 58 | TAOK1 | 0.98679661 |
| 59 | FLT3 | 0.98581999 |
| 60 | ERBB4 | 0.93679080 |
| 61 | SYK | 0.92416270 |
| 62 | IRAK2 | 0.91592767 |
| 63 | PDGFRA | 0.91294971 |
| 64 | PAK4 | 0.91024982 |
| 65 | ERN1 | 0.89160936 |
| 66 | KIT | 0.85585294 |
| 67 | CDK12 | 0.84944820 |
| 68 | JAK2 | 0.81911887 |
| 69 | SMG1 | 0.80351145 |
| 70 | RIPK4 | 0.80159144 |
| 71 | RPS6KA5 | 0.79966347 |
| 72 | EPHA2 | 0.78478936 |
| 73 | LRRK2 | 0.77853011 |
| 74 | ICK | 0.76903211 |
| 75 | MARK3 | 0.75893110 |
| 76 | MAP3K1 | 0.74673880 |
| 77 | DMPK | 0.73467666 |
| 78 | BMX | 0.70018948 |
| 79 | MAP2K2 | 0.69932233 |
| 80 | TAOK2 | 0.67856676 |
| 81 | PDGFRB | 0.66796421 |
| 82 | MAPKAPK2 | 0.65604990 |
| 83 | RPS6KA1 | 0.61848696 |
| 84 | MAP3K2 | 0.60983920 |
| 85 | MELK | 0.56906263 |
| 86 | GSK3A | 0.56757001 |
| 87 | CLK1 | 0.56692410 |
| 88 | ALK | 0.55650040 |
| 89 | ABL2 | 0.53889516 |
| 90 | PRKCQ | 0.51340837 |
| 91 | BRAF | 0.50994931 |
| 92 | CDK9 | 0.50723317 |
| 93 | PKN2 | 0.48657924 |
| 94 | TGFBR2 | 0.47408478 |
| 95 | SIK2 | 0.46711369 |
| 96 | BRD4 | 0.46702478 |
| 97 | TESK1 | 0.45961387 |
| 98 | MAPK11 | 0.42491388 |
| 99 | NME2 | 0.42147259 |
| 100 | DAPK3 | 0.40782402 |
| 101 | RET | 0.40245387 |
| 102 | TRPM7 | 0.40178392 |
| 103 | RPS6KB2 | 0.40044855 |
| 104 | MAPKAPK5 | 0.39212211 |
| 105 | CDK6 | 0.39154017 |
| 106 | STK24 | 0.39043488 |
| 107 | PTK2 | 0.38143685 |
| 108 | MAPK7 | 0.37731762 |
| 109 | RPS6KA6 | 0.37282898 |
| 110 | LYN | 0.36104772 |
| 111 | ABL1 | 0.35509676 |
| 112 | BMPR2 | 0.35281989 |
| 113 | BLK | 0.35160098 |
| 114 | SIK1 | 0.35127947 |
| 115 | PASK | 0.34195997 |
| 116 | CSF1R | 0.33939072 |
| 117 | TYRO3 | 0.33356301 |
| 118 | CDK4 | 0.33033157 |
| 119 | INSR | 0.32848049 |
| 120 | MAP3K8 | 0.32490542 |
| 121 | TTN | 0.32133078 |
| 122 | MAP3K5 | 0.32032762 |
| 123 | MAPKAPK3 | 0.31203527 |
| 124 | DYRK1B | 0.30392510 |
| 125 | PIK3CG | 0.29695779 |
| 126 | TESK2 | 0.29601598 |
| 127 | NEK9 | 0.29520390 |
| 128 | MAPK4 | 0.29021866 |
| 129 | TGFBR1 | 0.28521740 |
| 130 | MAP3K7 | 0.27644266 |
| 131 | PDK1 | 0.27447148 |
| 132 | PDPK1 | 0.26538968 |
| 133 | EIF2AK2 | 0.24885087 |
| 134 | EGFR | 0.24855753 |
| 135 | PKN1 | 0.24275703 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.93669239 |
| 2 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.78694656 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.71138772 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.51758711 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.51408830 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.49978784 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.49497369 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.34672381 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.32906298 |
| 10 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.24055695 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.23915068 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.06436878 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.99129638 |
| 14 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.90957296 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.83337773 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.74356607 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 1.74143960 |
| 18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.72860975 |
| 19 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.71936293 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.69393592 |
| 21 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.63072323 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.62945985 |
| 23 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.58072890 |
| 24 | Apoptosis_Homo sapiens_hsa04210 | 1.57298272 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.51569985 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.50260293 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.46872023 |
| 28 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.44688192 |
| 29 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.42523404 |
| 30 | Shigellosis_Homo sapiens_hsa05131 | 1.38656448 |
| 31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.37954322 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.36467195 |
| 33 | Hepatitis B_Homo sapiens_hsa05161 | 1.35211301 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.33544636 |
| 35 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.31844572 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.29450461 |
| 37 | Lysosome_Homo sapiens_hsa04142 | 1.28624989 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.27788908 |
| 39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.26327303 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.23141198 |
| 41 | Malaria_Homo sapiens_hsa05144 | 1.22728052 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.22587647 |
| 43 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.15032534 |
| 44 | Prion diseases_Homo sapiens_hsa05020 | 1.11396108 |
| 45 | Tuberculosis_Homo sapiens_hsa05152 | 1.09137411 |
| 46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.07011419 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 1.06018698 |
| 48 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.05727008 |
| 49 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.04221630 |
| 50 | HTLV-I infection_Homo sapiens_hsa05166 | 1.03454848 |
| 51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.03391849 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.02658345 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.00873262 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.99161361 |
| 55 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.98561045 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 0.98375425 |
| 57 | Hepatitis C_Homo sapiens_hsa05160 | 0.97388618 |
| 58 | Circadian rhythm_Homo sapiens_hsa04710 | 0.97002287 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.94755184 |
| 60 | Asthma_Homo sapiens_hsa05310 | 0.92197038 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.90902940 |
| 62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.87468273 |
| 63 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.81830485 |
| 64 | Platelet activation_Homo sapiens_hsa04611 | 0.79660362 |
| 65 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.79181817 |
| 66 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.77409819 |
| 67 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.77035208 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76854325 |
| 69 | Phagosome_Homo sapiens_hsa04145 | 0.76262920 |
| 70 | Colorectal cancer_Homo sapiens_hsa05210 | 0.75072017 |
| 71 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.71128360 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.68696741 |
| 73 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.67527930 |
| 74 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.66766224 |
| 75 | Prostate cancer_Homo sapiens_hsa05215 | 0.66126311 |
| 76 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.64463057 |
| 77 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.63993436 |
| 78 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63411098 |
| 79 | Amoebiasis_Homo sapiens_hsa05146 | 0.60882539 |
| 80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59720342 |
| 81 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.57996457 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57469429 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.55181804 |
| 84 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54132602 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53610594 |
| 86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53204562 |
| 87 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51538428 |
| 88 | Adherens junction_Homo sapiens_hsa04520 | 0.50670264 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49868980 |
| 90 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49679444 |
| 91 | Focal adhesion_Homo sapiens_hsa04510 | 0.47215767 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.46978367 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46425268 |
| 94 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.46218860 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.45716705 |
| 96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44656171 |
| 97 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.43067838 |
| 98 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.42632751 |
| 99 | Pathways in cancer_Homo sapiens_hsa05200 | 0.41932678 |
| 100 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41808784 |
| 101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.40744187 |
| 102 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.40252699 |
| 103 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39719305 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39440512 |
| 105 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.38428773 |
| 106 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37107255 |
| 107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36467945 |
| 108 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.36338833 |
| 109 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.35932380 |
| 110 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35825547 |
| 111 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.35631067 |
| 112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34469567 |
| 113 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34051039 |
| 114 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.32467168 |
| 115 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.30640572 |
| 116 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.30382850 |
| 117 | Bladder cancer_Homo sapiens_hsa05219 | 0.30336066 |
| 118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27281158 |
| 119 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.25378745 |
| 120 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.22895757 |

